Papers

5

Total Citations

109

H-Index

3

About

Dr. Johanne G. Bloemen is a leading colorectal surgeon whose research is revolutionizing the safety and quality of life in minimally invasive rectal cancer surgery. Her most impactful work centers on preventing anastomotic leakage, a devastating complication, through her landmark AVOID trial (84 citations). This multicentre, randomized, phase 3 study demonstrated that indocyanine green near-infrared fluorescence bowel perfusion assessment can significantly reduce leakage rates, establishing a new standard of intraoperative care. Dr. Bloemen is also a key figure in the comparative effectiveness of surgical techniques. She has authored a highly-cited systematic review and meta-analysis (16 citations) comparing functional outcomes and quality of life after open, laparoscopic, robot-assisted, and transanal total mesorectal excision (TME). Through her leadership in the EUREKA collaborative, she is spearheading a large, multinational cohort study to provide definitive data on robotic TME outcomes. Her work also addresses high-risk populations, such as overweight and obese patients, and identifies predictors for positive circumferential resection margins, directly informing strategies to improve oncological outcomes and patient survival.

Research Focus

Key Achievements

3
H-Index
5
Papers
109
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
Indocyanine green near-infrared fluorescence bowel perfusion assessment to prevent anastomotic leakage in minimally invasive colorectal surgery (AVOID): a multicentre, randomised, controlled, phase 3 trial
84 citations · 2024
📈 Most Prolific Year: 2024 (4 Papers)
🤝 Key Collaborators: 109
🏛 Institutions: Radboud University Nijmegen, University Medical Center Groningen, Portsmouth Hospitals NHS Trust

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 16 days ago